Malaria & Critical illness
The aim of the Malaria & Critical Illness Department at MORU is to improve health through research that addresses threats arising from malaria for billions of people who live in malaria endemic zones around the globe.
Billions of people live in malaria endemic countries; we aim to improve health through research that addresses this threat.
The Wellcome-MORU supported CRIT Care Asia (CCA) platform enables International Severe Acute Respiratory and emerging Infections Consortium (ISARIC) and WHO compliant real-time reporting of severe acute respiratory infections (SARI) critical care admissions from 11 South Asia and sub-Saharan African countries. CCA COVID -19 data is contributing to local, national and international research, and supporting service delivery. CCA is a collaborator of LOGIC, an international quality improvement consortium of ICU registries spanning four continents.
The Malaria & Critical Illness team published 96 papers in 2018, and 222 papers from 2015-2017, of which many in leading journals. Since its conception in 1979, the Malaria team has published over 1,000 papers.
Following the large multi-centre multi-country TRAC II study on triple ACTs (TACTs) to treat multi-drug resistant falciparum malaria, DeTACT, a large project funded by DFID, will expand the evaluation of TACTs to African countries and aims to have 2 different TACTs ready for deployment by the end of the project.
The Malaria & Critical Illness Department has a vibrant and productive network of collaborative study sites throughout South-East Asia, South Asia and Africa, with around 15 studies currently operating in a total of an equal number of countries.